These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17981212)

  • 21. The pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic Fatty liver disease and correlates with plasma caspase-3/7 activity.
    Schrieber SJ; Wen Z; Vourvahis M; Smith PC; Fried MW; Kashuba AD; Hawke RL
    Drug Metab Dispos; 2008 Sep; 36(9):1909-16. PubMed ID: 18566043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intra portal donor specific antigen transfusion might prevent re-infection of hepatitis C virus after living related liver transplantation in hepatitis C hepatic cirrhosis.
    Sato Y; Oya H; Yamamoto S; Kobayashi T; Watanabe T; Kokai H; Yamagiwa S; Hatakeyama K
    Hepatogastroenterology; 2009; 56(89):205-7. PubMed ID: 19453058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
    Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological and clinical aspects of liver cirrhosis in adult patients living in Southeastern Anatolia: leading role of HBV in 505 cases.
    Bayan K; Yilmaz S; Tuzun Y; Yildirim Y
    Hepatogastroenterology; 2007 Dec; 54(80):2198-202. PubMed ID: 18265632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transferable clastogenic activity in plasma from patients with Fanconi anemia.
    Emerit I; Levy A; Pagano G; Pinto L; Calzone R; Zatterale A
    Hum Genet; 1995 Jul; 96(1):14-20. PubMed ID: 7607648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C and diabetes: the inevitable coincidence?
    Lonardo A; Adinolfi LE; Petta S; Craxì A; Loria P
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):293-308. PubMed ID: 19344243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress in Adamantiades-Behçet's disease.
    Freitas JP; Filipe P; Yousefi A; Emerit I; Guerra Rodrigo F
    Dermatology; 1998; 197(4):343-8. PubMed ID: 9873172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.
    Fabris C; Toniutto P; Falleti E; Fontanini E; Cussigh A; Bitetto D; Fornasiere E; Fumolo E; Avellini C; Minisini R; Pirisi M
    Alcohol Clin Exp Res; 2009 Jan; 33(1):102-7. PubMed ID: 18945219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
    Loguercio C; Federico A; Masarone M; Torella R; Blanco Cdel V; Persico M
    Am J Gastroenterol; 2008 Dec; 103(12):3159-66. PubMed ID: 18786125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined analysis of interferon-gamma and interleukin-10 gene polymorphisms and chronic hepatitis C severity.
    Bouzgarrou N; Hassen E; Farhat K; Bahri O; Gabbouj S; Maamouri N; Ben Mami N; Saffar H; Trabelsi A; Triki H; Chouchane L
    Hum Immunol; 2009 Apr; 70(4):230-6. PubMed ID: 19480854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center study.
    Abdel-Wahab M; Mostafa M; Sabry M; el-Farrash M; Yousef T
    Hepatogastroenterology; 2008; 55(86-87):1754-9. PubMed ID: 19102385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors after liver resection for hepatocellular carcinoma with hepatitis B virus-related cirrhosis: surgeon's role in survival.
    Zhang XF; Meng B; Qi X; Yu L; Liu C; Liu XM; Wang B; Pan CE; Lv Y
    Eur J Surg Oncol; 2009 Jun; 35(6):622-8. PubMed ID: 18835514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C.
    Matsuoka S; Nirei K; Tamura A; Nakamura H; Matsumura H; Oshiro S; Arakawa Y; Yamagami H; Tanaka N; Moriyama M
    Intervirology; 2008; 51(5):352-61. PubMed ID: 19127078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    Bortolami M; Kotsafti A; Cardin R; Farinati F
    J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of hilar cholangiocarcinoma in Egypt: single center study.
    Abdel Wahab M; Mostafa M; Salah T; Fouud A; Kandeel T; Elshobary M; Abd Allah OF; Elghawalby N; Sultan A; Ezzat F
    Hepatogastroenterology; 2007 Sep; 54(78):1626-31. PubMed ID: 18019680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis status and mortality in hemodialysis population.
    Santoro D; Mazzaglia G; Savica V; Li Vecchi M; Bellinghieri G
    Ren Fail; 2009; 31(1):6-12. PubMed ID: 19142803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etiology of hepatocellular carcinoma in Argentina: results of a multicenter retrospective study.
    Fassio E; Míguez C; Soria S; Palazzo F; Gadano A; Adrover R; Landeira G; Fernández N; García D; Barbero R; Perelstein G; Ríos B; Isla R; Civetta E; Pérez Ravier R; Barzola S; Curciarello J; Colombato LA; Jmeniltzky A
    Acta Gastroenterol Latinoam; 2009 Mar; 39(1):47-52. PubMed ID: 19408739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of serum soluble Fas, Fas ligand and fas in intrahepatic lymphocytes in chronic hepatitis C.
    Zaki Mel S; Auf FA; Ghawalby NA; Saddal NM
    Immunol Invest; 2008; 37(2):163-70. PubMed ID: 18300041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.